跳转至内容
Merck
CN
  • Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers.

Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers.

Oncogene (2015-06-16)
E Marques, J I Englund, T A Tervonen, E Virkunen, M Laakso, M Myllynen, A Mäkelä, M Ahvenainen, T Lepikhova, O Monni, S Hautaniemi, J Klefström
摘要

Differentiated epithelial structure communicates with individual constituent epithelial cells to suppress their proliferation activity. However, the pathways linking epithelial structure to cessation of the cell proliferation machinery or to unscheduled proliferation in the context of tumorigenesis are not well defined. Here we demonstrate the strong impact of compromised epithelial integrity on normal and oncogenic Myc-driven proliferation in three-dimensional mammary epithelial organoid culture. Systematic silencing of 34 human homologs of Drosophila genes, with previously established functions in control of epithelial integrity, demonstrates a role for human genes of apico-basal polarity, Wnt and Hippo pathways and actin dynamics in regulation of the size, integrity and cell proliferation in organoids. Perturbation of these pathways leads to diverse functional interactions with Myc: manifested as a RhoA-dependent synthetic lethality and Par6-dependent effects on the cell cycle. Furthermore, we show a role for Par6G as a negative regulator of the phosphatidylinositol 3'-kinase/phosphoinositide-dependent protein kinase 1/Akt pathway and epithelial cell proliferation and evidence for frequent inactivation of Par6G gene in epithelial cancers. The findings demonstrate that determinants of epithelial structure regulate the cell proliferation activity via conserved and cancer-relevant regulatory circuitries, which are important for epithelial cell cycle restriction and may provide new targets for therapeutic intervention.

材料
货号
品牌
产品描述

Sigma-Aldrich
MISSION® esiRNA, targeting human TAF8